Tumour necrosis factor α independent disease mechanisms in rheumatoid arthritis: A histopathological study on the effect of infliximab on rheumatoid nodules

Annals of the Rheumatic Diseases

Volumn 63, Issue 5, 2004, Pages 489-493

  Baeten, D ^a   De Keyser, F ^a   Veys, E M ^a   Theate, Y ^b   Houssiau, F A ^b   Durez, P ^b  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; CELL MARKER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; METHOTREXATE; PARAFFIN; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL; CELL COUNT; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG EFFECT; FEMALE; FROZEN SECTION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MACROPHAGE; MALE; NECROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; STAINING; SYNOVITIS; T LYMPHOCYTE;

AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; FEMALE; HUMANS; MALE; MIDDLE AGED; RHEUMATOID NODULE; SYNOVITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1942532227     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.012302     Document Type: Article

References (15)

1. Veys EM, De Keyser F. Rheumatoid nodules: differential diagnosis and immunohistological findings. Ann Rneum Dis 1993;52:625-6.
2. Edwards JCW, Wilkinson LS, Pitsillides AA. Palisading cells of rheumatoid nodules: comparison with synovial intimal cells. Ann Rheum Dis 1993;52:801-5.
3. Kerstens PJ, Boerbooms AM, Jeurissen ME, Fast JH, Assmann KJ, van de Putte LB. Accelerated nodulosis during low dose MTX therapy for rheumatoid arthritis: an analysis of ten cases. J Rheumatol 1992;19:867-71.
4. Kaiser MJ, Bozonnat MC, Jorgensen C, Daures JP, Sany J. Effect of etanercept on tenosynovitis and nodules in rheumatoid arthritis. Arthritis Rheum 2002;46:559-60.
5. Cunnane G, Warnock M, Fye KH, Daikh DI. Accelerated nodulosis and vacsulitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum 2002;47:445-9.
6. Kekow J, Welte T, Kellner U, Pap T. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept. Arthritis Rheum 2002;46:843-4.
7. Baeten D, Kruithof E, Van Den Bosch F, Demetter P, Van Damme N, Cuvelier C, et al. Immunomodulatory effects of anti-TNF-α therapy on synovium in spondyloarthropathy: histologic findings in eight patients from an open-label pilot study. Arthritis Rheum 2001;44:186-95.
8. Elewaut D, de Keyser F, De Wever N, Baeten D, van Damme N, Verbruggen G, et al. A comparative phenotypical analysis of rheumatoid nodules and rheumatoid synovium with special reference to adhesion molecules and activation markers. Ann Rheum Dis 1998;57:480-6.
9. Wikaningrum R, Highton J, Parker A, Coleman M, Hessian PA, Roberts-Thomson PJ, et al. Pathogenic mechanisms in the rheumatoid nodule: comparison of proinflammatory cytokine production and cell adhesion molecule expression in rheumatoid nodules and synovial membranes from the same patients. Arthritis Rheum 1998;41:1783-97.
10. Tak PP, Taylor PC, Breedveld FC, Smeets TJM, Daha ME, Kluin PM, et al. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor α monocloncal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1077-81.
11. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
12. Merrill JT, Shen C, Schreibman D, Coffey D, Zakharenko O, Fisher R, et al. Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: o mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Arthritis Rheum 1997;40:1308-15.
13. Edwards JCW, Cambridge G. Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen. Br J Rheumatol 1998;37:126-30.
14. Edwards JCW, Blades S, Cambridge G. Restricted expression of FcγRIII (CD16) in synovium and dermis: implications for tissue targeting in rheumatoid arthritis. Clin Exp Immunol 1997;108:401-6.
15. Morgan AW, Griffiths B, Ponchel F, Montague BMN, Ali M, Gardner PP, et al. Fcγ receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Arthritis Rheum 2000;23:28-34.